X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Elder Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
TEVA PHARMA
Dec-13
ELDER PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3802,929-   
Low Rs1882,545-   
Sales per share (Unadj.) Rs491.21,681.2-  
Earnings per share (Unadj.) Rs-3.2105.0-  
Cash flow per share (Unadj.) Rs14.4240.9-  
Dividends per share (Unadj.) Rs091.94-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs376.51,867.5-  
Shares outstanding (eoy) m20.54848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.6 35.5%   
Avg P/E ratio x-89.326.1 -342.5%  
P/CF ratio (eoy) x19.711.4 173.5%  
Price / Book Value ratio x0.81.5 51.5%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m5,8332,320,993 0.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM31,719.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,981.5-  
INCOME DATA
Net Sales Rs m10,0891,425,637 0.7%  
Other income Rs m2570-   
Total revenues Rs m10,3461,425,637 0.7%   
Gross profit Rs m-792390,411 -0.2%  
Depreciation Rs m361115,236 0.3%   
Interest Rs m2,75628,002 9.8%   
Profit before tax Rs m-3,653247,174 -1.5%   
Minority Interest Rs m01,123 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-162,256 -2.3%   
Tax Rs m125-3,018 -4.1%   
Profit after tax Rs m-6589,058 -0.1%  
Gross profit margin %-7.827.4 -28.7%  
Effective tax rate %-3.4-1.2 280.6%   
Net profit margin %-0.66.2 -10.4%  
BALANCE SHEET DATA
Current assets Rs m9,240962,870 1.0%   
Current liabilities Rs m9,998839,704 1.2%   
Net working cap to sales %-7.58.6 -86.9%  
Current ratio x0.91.1 80.6%  
Inventory Days Days4691 51.0%  
Debtors Days Days6096 62.5%  
Net fixed assets Rs m10,124465,644 2.2%   
Share capital Rs m2063,509 5.9%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,7341,583,612 0.5%   
Long term debt Rs m4,889728,960 0.7%   
Total assets Rs m22,8823,258,036 0.7%  
Interest coverage x-0.39.8 -3.3%   
Debt to equity ratio x0.60.5 137.3%  
Sales to assets ratio x0.40.4 100.8%   
Return on assets %11.83.6 327.3%  
Return on equity %-0.85.6 -15.0%  
Return on capital %22.34.9 452.4%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754227,173 5.2%  
From Investments Rs m-561-80,496 0.7%  
From Financial Activity Rs m-6,762-272,509 2.5%  
Net Cashflow Rs m4,432-125,833 -3.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.18 Rs / USD

Compare ELDER PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ELDER PHARMA With: CIPLA  DR. DATSONS LABS  SUVEN LIFE  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - DIVIS LABORATORIES COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS